Why the study?
High-risk pulmonary embolism carries remarkably high mortality and reperfusion is underused, but epidemiological data regarding incidence, reperfusion rates, and mortality were unknown in Portugal.
Does reperfusion treatment reduce in-hospital mortality in patients with high-risk pulmonary embolism?
Does reperfusion treatment reduce in-hospital mortality in patients with high-risk pulmonary embolism?
Reperfusion therapy is associated with significantly lower in-hospital mortality in patients with high-risk pulmonary embolism, highlighting the need to increase its utilization.
Answers are grounded in this paper and cite their sources.
May support reperfusion consideration in high-risk PE; leaves open causal confirmation by RCTs.
BACKGROUND: The mortality associated with high-risk pulmonary embolism (PE) is remarkably high, and reperfusion to unload right ventricle should be a priority. However, several registries report reperfusion underuse. In Portugal, epidemiological data about the incidence, rate of reperfusion and mortality of high-risk PE are not known. METHODS: Nationwide population-based temporal trend study in the incidence and outcome of high-risk PE, who were admitted to hospitals of the National Health Service in Portugal between 2010 and 2018. High-risk PE was defined as patients with PE who developed cardiogenic shock or cardiac arrest. International Classification of Diseases (ICD), 9th and 10th revision, Clinical Modification codes, were used for data from the period between 2010 and 2016 (ICD-9-CM) and 2017-2018 (ICD-10-CM), respectively. The assessment focused on trends in the use of reperfusion treatment, which was defined by application of thrombolysis or pulmonary embolectomy. A comparison was made between the use or non-use of reperfusion therapy in order to examine trends in in-hospital mortality among high-risk PE cases. Surgical pulmonary embolectomy was used in 0.27% of cases, and there was no registry of catheter-directed thrombolysis. Patients with high-risk PE undergoing reperfusion therapy had lower in-hospital mortality compared to non-reperfused patients (OR=0.52; IC95% 0.38-0.70). CONCLUSION: In Portugal, between 2010 and 2018, very few patients with PE developed high-risk forms of the disease, but the mortality rate among those patients was high. The low reperfusion rate could be associated with high in-hospital mortality and highlights the need to implement advanced therapies, as an alternative to systemic thrombolysis.
No takes yet. Share an insight, caveat, or question.
Calé et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: